40
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Role of High-Frequency Audiometry in the Early Detection of Ototoxicity: II. Clinical Aspects

, , &
Pages 211-220 | Received 26 Jan 1988, Accepted 10 Nov 1988, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Stephen A. Fausti, Deanna J. Olson, Richard H. Frey, James A. Henry, Heidi I. Schaffer & David S. Phillips. (1995) High-frequency Toneburst-evoked ABR Latency-intensity Functions in Sensorineural Hearing-impaired Humans. Scandinavian Audiology 24:1, pages 19-25.
Read now

Articles from other publishers (22)

Magdalena B. Skarzynska, Monika Matusiak & Piotr H. Skarzynski. (2022) Adverse Audio-Vestibular Effects of Drugs and Vaccines Used in the Treatment and Prevention of COVID-19: A Review. Audiology Research 12:3, pages 224-248.
Crossref
M. Emrah Kınal, Arzu Tatlıpınar, Selami Uzun, Serhan Keskin, Emrah Tekdemir, Dilek Özbeyli & Dilek Akakın. (2019) Investigation of Astaxanthin Effect on Cisplatin Ototoxicity in Rats by Using Otoacoustic Emission, Total Antioxidant Capacity, and Histopathological Methods. Ear, Nose & Throat Journal 100:4, pages NP198-NP205.
Crossref
Katijah Khoza-Shangase. (2020) Pharmaco-Audiology Vigilance in the Treatment of Adult Patients with HIV/Aids: Ototoxicity Monitoring Protocol Recommendation. Infectious Disorders - Drug Targets 20:1, pages 33-42.
Crossref
Magdalena Skarzynska, Bartłomiej Krol, Natalia Czajka & Łukasz Czajka. (2020) OTOTOXICITY OF DRUGS USED IN THE TREATMENT OF COVID-19. Journal of Hearing Science 10:1, pages 9-20.
Crossref
Gayla L. Poling, Brittany Vlosich & Laura E. Dreisbach. (2019) Emerging Distortion Product Otoacoustic Emission Techniques to Identify Preclinical Warning Signs of Basal Cochlear Dysfunction Due to Ototoxicity. Applied Sciences 9:15, pages 3132.
Crossref
Emilia Peleva, Nader Emami, Mohammad Alzahrani, Aren Bezdjian, Joshua Gurberg, Anne-Sophie Carret & Sam J. Daniel. (2014) Incidence of platinum-induced ototoxicity in pediatric patients in Quebec. Pediatric Blood & Cancer 61:11, pages 2012-2017.
Crossref
Deep Kwatra. (2013) Drug delivery in ocular diseases: Barriers and strategies. World Journal of Pharmacology 2:4, pages 78.
Crossref
Daniela Cecílio Capra Marques de Oliveira & Marco Antonio de Melo Tavares de Lima. (2009) Low and high frequency tonal threshold audiometry: comparing hearing thresholds between smokers and non-smokers. Brazilian Journal of Otorhinolaryngology 75:5, pages 738-744.
Crossref
Shawn S. Goodman, Denis F. Fitzpatrick, John C. Ellison, Walt Jesteadt & Douglas H. Keefe. (2009) High-frequency click-evoked otoacoustic emissions and behavioral thresholds in humans. The Journal of the Acoustical Society of America 125:2, pages 1014-1032.
Crossref
Kelly M. Reavis, David S. Phillips, Stephen A. Fausti, Jane S. Gordon, Wendy J. Helt, Debra Wilmington, Gene W. Bratt & Dawn Konrad-Martin. (2008) Factors Affecting Sensitivity of Distortion-Product Otoacoustic Emissions to Ototoxic Hearing Loss. Ear & Hearing 29:6, pages 875-893.
Crossref
Lilian Cassia Bornia Jacob, Fabrina Pavia Aguiar, Aline Aparecida Tomiasi, Samira Natacha Tschoeke & Raquel Fava de Bitencourt. (2006) Monitoramento auditivo na ototoxidade. Revista Brasileira de Otorrinolaringologia 72:6, pages 836-844.
Crossref
Lilian Cassia Bornia Jacob, Fabrina Pavia Aguiar, Aline Aparecida Tomiasi, Samira Natacha Tschoeke & Raquel Fava de Bitencourt. (2006) Auditory monitoring in ototoxicity. Brazilian Journal of Otorhinolaryngology 72:6, pages 836-844.
Crossref
Miguel Angelo Hyppolito, José Antonio A. de Oliveira, Ricardo Miranda Lessa & Maria Rossato. (2005) Amifostine otoprotection to cisplatin ototoxicity: a guinea pig study using otoacoustic emission distortion products (DPOEA) and scanning electron microscopy. Brazilian Journal of Otorhinolaryngology 71:3, pages 268-273.
Crossref
Adriana P. Garcia, Maria Cecília M. Iório & Antônio S. Petrilli. (2003) Monitoramento da audição de pacientes expostos à cisplatina. Revista Brasileira de Otorrinolaringologia 69:2, pages 215-221.
Crossref
Lawrence I. ShotlandFrank G. OndreyKristen A. MayoJaye L. Viner. (2001) Recommendations for Cancer Prevention Trials Using Potentially Ototoxic Test Agents. Journal of Clinical Oncology 19:6, pages 1658-1663.
Crossref
Joel L. Mattsson. (2016) Ototoxicity: An Argument for Evaluation of the Cochlea in Safety Testing in Animals. Toxicologic Pathology 28:1, pages 137-141.
Crossref
P. Bonfils, T. Van Den Abbeele, P. Ané & P. Avan. (2000) Exploración funcional auditiva. EMC - Otorrinolaringología 29:1, pages 1-19.
Crossref
Balwant S. Gendeh, Alan G. Gibb, Nik S. Aziz, Norella Kong & Zaki M. Zahir. (2016) Vancomycin administration in continuous ambulatory peritoneal dialysis: The risk of ototoxicity. Otolaryngology–Head and Neck Surgery 118:4, pages 551-558.
Crossref
John C.M.J de Groot, Frank P.T Hamers, Willem-Hendrik Gispen & Guido F Smoorenburg. (1997) Co-administration of the neurotrophic ACTH(4-9) analogue, ORG2766, may reduce the cochleotoxic effects of cisplatin. Hearing Research 106:1-2, pages 9-19.
Crossref
Kay Rabbitt Park. (1996) The Utility of Acoustic Reflex Thresholds and Other Conventional Audiologic Tests for Monitoring Cisplatin Ototoxicity in the Pediatric Population. Ear and Hearing 17:2, pages 107-115.
Crossref
Kathleen C.M. Campbell & John Durrant. (1993) Audiologic Monitoring for Ototoxicity. Otolaryngologic Clinics of North America 26:5, pages 903-914.
Crossref
P J GovaertsJ ClaesP H Van de HeyningM P DerdeL KaufmanJ F MarquetM E De Broe. (1991) Effect of isepamicin dosing scheme on concentration in cochlear tissue. Antimicrobial Agents and Chemotherapy 35:11, pages 2401-2406.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.